Original Article

Patterns of bronchodilator therapy in asthmatic outpatients

Toetik Aryani, Riska K. Rahmawati, Ni P. Cintyadewi, Arina D. Puspitasari, Alfian N. Rasyid, Samirah Samirah
Journal of Public Health in Africa | Vol 14, S 1 : 4th Joint Conference of UNAIR-USM, International Conference of Pharmacy and Health Sciences ICPHS| a164 | DOI: https://doi.org/10.4081/jphia.2023.2533 | © 2024 Toetik Aryani, Riska K. Rahmawati, Ni P. Cintyadewi, Arina D. Puspitasari, Alfian N. Rasyid, Samirah Samirah | This work is licensed under CC Attribution 4.0
Submitted: 05 April 2024 | Published: 30 March 2023

About the author(s)

Toetik Aryani, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Riska K. Rahmawati, Magister of Clinical Pharmacy Program, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Ni P. Cintyadewi, Bachelor of Pharmacy Program, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Arina D. Puspitasari, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Alfian N. Rasyid, Pulmonary Department, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Samirah Samirah, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia

Full Text:

PDF (631KB)

Abstract

Background: Bronchodilators are used to treat asthma symptoms. The administration of this therapy can be given through monotherapy or in combination to achieve the maximum therapeutic effect. Objective: This study aimed to examine the prescribing pattern of bronchodilators in asthmatic outpatients. Methods: A retrospective study was done by reviewing and analyzing medical records of asthmatic outpatients from January 2019 until December 2020. Data analysis was performed descriptively. Results: In this study, bronchodilators were administered by inhalation 97.4% compared to oral routes 2.6%. Combination bronchodilator therapy showed 54.7% compared to monotherapy by 46.3%. The combination ICS/LABA budesonide/formoterol 160/4.5 mcg was the most widely used 45.7%. Conclusion: The use of a bronchodilator was in accordance with the Global Initiative for Asthma guidelines. The route of drug administration through inhalation is more widely used than oral. Combination bronchodilators were more recommended than bronchodilator monotherapy to control asthma symptoms.

Keywords

Asthma; β2 agonists; Muscarinic antagonist; Inhaled corti-costeroids

Metrics

Total abstract views: 174
Total article views: 23

 

Crossref Citations

1. Combined therapy of broncho-obstructive pathology: two solutions to one problem
A. A. Vizel, I. Yu. Vizel
Meditsinskiy sovet = Medical Council  issue: 20  first page: 28  year: 2023  
doi: 10.21518/ms2023-302